Antisocial Personality Disorder as a Risk Factor for Opioid Use: The Dual Mediating Roles of Antisocial Attitudes and Self-Control

DOI10.1177/0022042620979630
AuthorThomas Wojciechowski
Date01 April 2021
Published date01 April 2021
Subject MatterArticles
https://doi.org/10.1177/0022042620979630
Journal of Drug Issues
2021, Vol. 51(2) 264 –279
© The Author(s) 2020
Article reuse guidelines:
sagepub.com/journals-permissions
DOI: 10.1177/0022042620979630
journals.sagepub.com/home/jod
Article
Antisocial Personality Disorder as
a Risk Factor for Opioid Use: The
Dual Mediating Roles of Antisocial
Attitudes and Self-Control
Thomas Wojciechowski1
Abstract
Antisocial personality disorder is a risk factor for opioid use. There is a dearth of research which
examines self-control and moral disengagement as potential mediators of this relationship. This
study utilized data from the Pathways to Desistance study in analyses. Generalized structural
equation modeling was utilized to test for mediation of the relationship between antisocial
personality disorder and opioid use. Bootstrapped standard errors were computed so that
a Clogg Z test could be estimated to determine if identified mediation effects significantly
differed. Results indicated that a likely diagnosis of antisocial personality disorder increased risk
for opioid use. Inclusion of moral disengagement and self-control into the model resulted in
attenuation of this effect to non-significance and reduced the magnitude of the effect by around
45%. The contribution of both constructs to the total indirect effect did not significantly differ
and only the total indirect effect was significant.
Keywords
antisocial personality disorder, opioids, moral disengagement, self-control
Introduction
Opioids and opiates belong to a class of drugs that cause euphoria and pain relief, among other
effects. Opiates specifically are naturally derived from the poppy plant, whereas opioids are syn-
thetic and constructed in a lab to produce similar effects to opiates. The term opioids will be used
throughout the article to describe both for ease of reading. Antisocial personality disorder (ASPD)
is a psychiatric illness that can be pervasive in its impact on social functioning. To meet the cri-
teria for ASPD, individuals must demonstrate a disregard for the rights of others,1 have evidence
of onset of conduct disorder prior to age 15, be at least 18 years old, and occurrence cannot
exclusively happen during the course of schizophrenia or bipolar disorder (Diagnostic and
Statistical Manual of Mental Disorders [5th ed.; DSM-5]; American Psychiatric Association,
2013). ASPD afflicts between 0.2% and 3.3% every year (American Psychiatric Association,
2013). This pervasive disorder is associated with increased risk for opioid use (Kidorf et al.,
2004; Manseau & Compton, 2018; Smith et al., 2017). For example, Smith et al. (2017) found
1Michigan State University, East Lansing, USA
Corresponding Author:
Thomas Wojciechowski, School of Criminal Justice, Michigan State University, 655 Auditorium Road, East Lansing,
MI 48824, USA.
Email: wojcie42@msu.edu
979630JODXXX10.1177/0022042620979630Journal of Drug IssuesWojciechowski
research-article2020
Wojciechowski 265
that ASPD sufferers in rural areas who also used drugs were more likely to report past 30-day
heroin use than healthy counterparts. ASPD has also been found to be associated with increased
risk of comorbid opioid use disorder and sedative use disorder (Ellis et al., 2020). In these ways,
the disorder is contributing to the opioid crisis observed in the present day in the form of elevated
opioid use prevalence rates and elevated mortality rates (Vadivelu et al., 2018). Addressing the
disorder via programming may offer a means of mitigating the relationship between the disorder
and opioid use. While this would seem to entail a relatively straightforward approach, targeting
the specific aspects of ASPD that are more distinctly predictive of opioid use may provide a more
efficient means of addressing this issue. However, there is a dearth of research focused on iden-
tifying the characteristics of ASPD that actually lead to increased risk for opioid use.
Two characteristics of ASPD that may help to understand increased risk for opioid use among
this group are self-control and moral disengagement. Individuals with ASPD generally report
lower levels of self-control and more serious antisocial attitudes that are consistent with moral
disengagement (American Psychiatric Association, 2013; Bulten et al., 2009; Swann et al., 2009;
Umut et al., 2017). Both of these constructs have been identified as risk factors predicting height-
ened risk for substance use also. Despite these links, there is a dearth of research examining these
mechanisms as potential mediators of the ASPD–opioid use relationship. Relatedly, there is little
understanding of whether one of these constructs acts as a significantly stronger mediator of this
relationship. This is a major omission, as identifying whether or not one of these constructs offers
a more important pathway from ASPD to opioid use would allow for more efficient targeting of
resources for addressing the contribution of ASPD to the opioid crisis. This study sought to
address these gaps in the literature by examining this proposed direct effect of ASPD on opioid
use and testing for mediation through the identified dual pathways model.
One’s level of moral disengagement refers to psychological mechanisms by which individuals
can justify their perpetration of antisocial behavior (Bandura, 1991). There is largely an align-
ment between the concept of moral disengagement and techniques of neutralization (Sykes &
Matza, 1957), as both sets of concepts represent justifications and rationalizations that may be
deployed to explain away one’s violation of norms and the law as necessary. Eight dimensions of
moral disengagement have been identified: moral justification, euphemistic language, advanta-
geous comparison, displacement of responsibility, diffusion of responsibility, disregarding or
distorting the consequences of action, dehumanization, and attribution of blame. Endorsement of
such justifications or rationalizations is consistent with the symptomatic antisocial attitudes of
individuals afflicted with ASPD and justifications that they may use to disregard the rights of
others (e.g., Some people deserve to be treated like animals; It is okay to treat badly somebody
who behaved like a “worm” or a “low life.”; American Psychiatric Association, 2013). Research
has provided evidence of such a link between moral disengagement and behavior, as individuals
who report endorsement of more moral disengagement mechanisms are at greater risk for engage-
ment in a range of criminal behaviors (Ishoy, 2017; Risser & Eckert, 2016; Wang et al., 2017).
For example, Wang et al. (2017) found that moral disengagement mediated the relationship
between childhood maltreatment and bullying behaviors. This makes sense, as individuals who
report endorsement of more mechanisms seemingly would be more likely to deploy these justifi-
cations to rationalize their antisocial behavior and overcome issues associated with norm-break-
ing. In terms of opioid use specifically, there is currently a dearth of research which has examined
moral disengagement as a predictor. However, moral disengagement has been found to be a
predictor of other forms of psychoactive substance use (Jang, 2019; Newton et al., 2012; Passini,
2012), including performance and cognitive-enhancing drugs (Boardley et al., 2014, 2017; Heyes
& Boardley, 2019). Newton et al. (2012) found that higher moral disengagement scores were
associated with increased odds of ever drinking alcohol, past 3-month binge drinking, and ever
trying marijuana. Passini (2012) found that moral disengagement predicted both heavy drug use
and delinquency. For substance use generally, this would seem to operate in a manner consistent

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT